Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism by Minnone, G et al.
ORAL PRESENTATION Open Access
Low levels of the nerve growth factor receptor
TrkA in JIA: a possible defect in a novel anti-
inflammatory mechanism
G Minnone
1*, R Strippoli
1, G Prencipe
1, L De Pasquale
1, C Bracaglia
1, A Insalaco
1, F De Benedetti
1,
L Bracci-Laudiero
1,2
From 18th Pediatric Rheumatology European Society (PReS) Congress
Bruges, Belgium. 14-18 September 2011
Background
High levels of Nerve Growth Factor (NGF) are found in
chronic inflammatory diseases, including synovial fluids
(SF) of juvenile idiopathic arthritis (JIA) patients. The
effects of high NGF levels on immune cell activity and
inflammatory process are unknown.
Objective
To evaluate the effects of NGF and the role of its recep-
tor TrkA on cytokine production in monocytes, which
express TrkA and are key players of inflammation. To
investigate in JIA patients the expression of the NGF
receptor, TrkA, in blood and SF mononuclear cells
(MC).
Methods
Using real time PCR we evaluated the expression of
TrkA in JIA patients (n=25; mean age 8.93 years) and
controls comparable (n=17; mean age 8.93 years). In
human monocytes stimulated with LPS, the effect of
TrkA activation or inhibition on signalling and cytokine
release was evaluated using real-time PCR, western blot
and ELISA.
Results
Compared to controls, TrkA mRNA expression was
markedly lower in blood MC of JIA patients
(p<0.001). TrkA mRNA levels were similarlv low in SF
MC of JIA patients. In vitro, we show that addition of
NGF down-regulates IL-6 and IL-1 production and
increases IL-10. Blocking the receptor TrkA resulted
in enhanced activation of the NF-kB pathway, in
increased inflammatory cytokine production and in
decreased IL-10.
Conclusions
We show for the first time that NGF, through TrkA,
has anti-inflammatory effects on monocytes, suggesting
that the well-known NGF increase found in chronic
inflammatory diseases represents an endogenous
mechanisms limiting inflammatory response. Defective
TrkA expression, as found in JIA patients, may lead to
an imbalance between pro-inflammatory and anti-
inflammatory pathways contributing to chronic
inflammation.
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